Detecting microplastics in patients undergoing neurosurgery
Official title: Presence of Microplastics and Nanoplastics in Neurosurgery Patients
Run by Beijing Tiantan Hospital · NCT05968053 · Data updated 2026-11-12
This study is trying to see if tiny pieces of plastic are found in the blood, brain fluid, and brain tissue of patients who are having brain surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | September 25, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | January 23, 2025 |
| Trial ID | NCT05968053 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 18-80 who are scheduled for any type of neurosurgery.
✕Probably not a fit
Patients who refuse to participate in the study will not receive any benefit from the findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the presence of microplastics and nanoplastics in biological samples from patients undergoing neurosurgery. By analyzing blood, cerebrospinal fluid, and brain tissue, the study seeks to uncover whether these pollutants are present in the human body during surgical procedures. The research will involve collecting samples from a diverse group of neurosurgery patients to assess the extent of microplastic exposure in this specific population.
Why it matters
Potential benefit: If successful, this study could provide insights into the impact of microplastics on neurological health and inform future treatment strategies.
How similar studies have gone: While the investigation of microplastics in human tissues is a growing field, this specific approach in neurosurgery patients is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-80 years * Any type of neurosurgery Exclusion Criteria: ·refusal of the patient to participate
Where it's running
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Runting Li, MD — Beijing Tiantan Hospital
- Study coordinator: Xiaolin Chen, MD
- Email: cxl_bjtth@163.com
- Phone: 13810624845
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combining TIL Therapy and Pembrolizumab for Advanced Brain Cancer
This study is testing a new treatment that combines a type of immune therapy using patients' own tumor cells with Pembrolizumab to see if it helps people with advanced brain cancer feel better and live longer.
-
Evaluating Bevacizumab with Focused Ultrasound for Recurrent Glioblastoma
This study is testing if adding focused ultrasound to the standard treatment of Bevacizumab can help people with recurrent glioblastoma feel better and live longer.
-
Using MRI to Differentiate Between Brain Tumors and Radiation Effects
This study is testing a new MRI technique to see if it can help tell the difference between brain tumors and radiation damage in people who have had radiation therapy.
-
HOPE: Clinical, Pathology, and Imaging Project for Brain Tumors
This project collects clinical records, MRI scans, and pathology data from people with glioma and other primary brain tumors to build large databases for improving diagnosis and care.
-
Impact of Radiotherapy on Neurocognition in Brain Tumor Patients
This study is testing how radiotherapy affects thinking and memory in adults with brain tumors over time to see if certain treatments lead to cognitive decline.
-
Gene therapy combined with radiotherapy for brain tumors
This study is testing a new gene therapy combined with targeted radiation to see if it can safely help people with recurrent high-grade brain tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.